David Zimbalist

David Zimbalist

David is focused on the life sciences sector, which he has covered as an investment banker and equity research analyst for more than 25 years.  Prior to EC M&A, he ran the life science tools, biomanufacturing, and diagnostics investment banking effort at Janney Montgomery Scott, advising clients on equity financing and M&A. Before Janney, David was a senior banker for healthcare at Natixis, focused on corporate and sponsor acquisition activity in the US, Europe, and Asia.  He began his career as an equity research analyst covering medical devices, diagnostics, and life science tools at Schroders and Morgan Stanley.  David holds an MBA from Emory University’s Goizueta School of Business and a BA from the University of Pennsylvania

Professionals

Hans C. Hornbostel

Founder and Managing Director

Evan S. Yellin

Founder and Managing Director

Alan K. Granberg

Managing Director

Teresa Watson

Managing Director

Richard Kromka

Managing Director

Gerard E. Toohey

Managing Director

Pim Kraaijeveld

Managing Director

Volker Seekamp

Managing Director

Philippe Schmitt

Managing Director

Sally Sha

Managing Director

Monika Bansal

Managing Director

Malte Richter

Managing Director

David Zimbalist

Managing Director

Constantine Biller

Managing Director

Victoria W. Leung

Managing Director

Robert Sulma

Managing Director

Ewoma Oteri

Director

Helmut Laner

Director

Matthew Nicastro

Vice President

Cory J. Kenny

Vice President

Richard Hale

Business Development Director

David Morris

Business Development Director